Bionano Genomics Inc (BNGO) Stock Price, Quote & News

Company Profile

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-resu...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 858 888 7600

Website: bionano.com

Address:

9540 Towne Centre Drive, Suite 100, San Diego, United States

Lstreak Jun. 8 at 5:49 PM

$BNGO https://finance.yahoo.com/markets/stocks/articles/bionano-genomics-bngo-upgraded-buy-160005428.html

0 · Reply

MisterNessuno Jun. 8 at 4:28 PM

$BNGO Is obvius that this company will be sold by the end of year (Mr E, Alka,retire senior secured, ecc)

0 · Reply

Peaceouty Jun. 6 at 8:36 PM

$BNGO that was THE smartest person in this entire company.

0 · Reply

SuperGreenToday Jun. 6 at 12:42 AM

$BNGO

0 · Reply

focafoca99 Jun. 5 at 9:23 PM

$BNGO notified its Chief Medical Officer Alka Chaubey, Ph.D. will resign effective July 5, 2026. https://www.rapidticker.com/news/bngo-sec-filing-01375e

1 · Reply

JumpStarting Jun. 5 at 7:32 PM

$TLRY $FLNA $BNGO $SPX Good news should not be bad news!

0 · Reply

AdmiralTweezers Jun. 3 at 10:39 PM

$ILMN why are these genomics tech companies up?? $BNGO ???

1 · Reply

JinUzuki Jun. 3 at 9:39 PM

$BNGO GREEN IN A SEA OF RED BABY!!!! LFG!!!!……………

0 · Reply

Xochi_Research_Group Jun. 3 at 8:23 PM

$BNGO is it true ❓ is homolin finally gone ❓ may need to scale back in here.....

0 · Reply

geistvonspiez Jun. 3 at 6:50 PM

$BNGO i can smell something.

0 · Reply

Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures

2026-05-26T15:31:13.000Z - 13 days ago

Bionano Genomics announces OGM study of T-cell acute lymphoblastic leukemia

May 26, 2026, 8:00 AM EDT - 13 days ago

Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia

May 13, 2026, 4:30 PM EDT - 26 days ago

Bionano Genomics Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 26 days ago

Bionano Genomics Earnings release: Q1 2026

May 13, 2026, 4:30 PM EDT - 26 days ago

Bionano Genomics Quarterly report: Q1 2026

May 13, 2026, 4:30 PM EDT - 26 days ago

Bionano Genomics Slides: Q1 2026

May 13, 2026, 4:05 PM EDT - 26 days ago

Bionano Reports First Quarter 2026 Results and Provides a Business Update

2026-05-08T23:01:48.000Z - 4 weeks ago

Bionano Genomics files $400M mixed securities shelf

May 8, 2026, 8:00 AM EDT - 4 weeks ago

Bionano Genomics Registration statement: Registration filing

2026-05-07T00:20:18.000Z - 4 weeks ago

Bionano Genomics CEO Erik Holmlin to step down, Al Luderer to succeed

May 6, 2026, 4:30 PM EDT - 4 weeks ago

Bionano Announces Leadership Transition

May 5, 2026, 8:00 AM EDT - 4 weeks ago

Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025

Apr 29, 2026, 4:05 PM EDT - 5 weeks ago

Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026

2026-04-13T10:18:13.000Z - 2 months ago

Bionano Genomics price target lowered to $6 from $7 at H.C. Wainwright

Apr 2, 2026, 8:00 AM EDT - 2 months ago

Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma

Apr 2, 2026, 8:00 AM EDT - 2 months ago

Bionano Genomics Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 2 months ago

Bionano Genomics Proxy statement: Proxy filing

Mar 23, 2026, 4:30 PM EDT - 2 months ago

Bionano Genomics Earnings Call Transcript: Q4 2025

Mar 23, 2026, 4:30 PM EDT - 2 months ago

Bionano Genomics Annual report: Q4 2025

Mar 23, 2026, 4:30 PM EDT - 2 months ago

Bionano Genomics Earnings release: Q4 2025

Mar 23, 2026, 4:30 PM EDT - 2 months ago

Bionano Genomics Slides: Q4 2025

2026-03-23T20:16:27.000Z - 2 months ago

Bionano Genomics reports Q4 revenue $7.95M vs. $8.16M last year

2026-03-23T20:15:56.000Z - 2 months ago

Bionano Genomics sees Q1 revenue $6.5M-$6.7M

Mar 23, 2026, 4:05 PM EDT - 2 months ago

Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026

Mar 9, 2026, 4:05 PM EDT - 3 months ago

Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026

2026-02-27T13:11:08.000Z - 3 months ago

Bionano Genomics announces Bionano Symposium Day 4 highlights

Feb 27, 2026, 8:00 AM EST - 3 months ago

Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale

2026-02-26T13:37:50.000Z - 3 months ago

Bionano Genomics announces Bionano Symposium Day 3 highlights

Feb 26, 2026, 8:00 AM EST - 3 months ago

10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM's Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders

Feb 25, 2026, 8:00 AM EST - 3 months ago

11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy

2026-02-24T13:11:39.000Z - 3 months ago

Bionano Genomics announces Bionano Symposium Day 1 highlights

Feb 24, 2026, 8:00 AM EST - 3 months ago

9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies

2026-02-09T14:10:50.000Z - 4 months ago

Bionano Genomics announces Bionano Symposium 2026

Feb 9, 2026, 9:05 AM EST - 4 months ago

Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping

2026-02-04T13:21:16.000Z - 4 months ago

Bionano Genomics announces publication on OGM, gene editing technology

Feb 4, 2026, 8:00 AM EST - 4 months ago

Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies

2026-01-12T13:17:13.000Z - 5 months ago

Bionano Genomics reports preliminary Q4 revenue $7.8M-$8M

2025-12-11T13:26:28.000Z - 6 months ago

Bionano Genomics recaps advances in OGM showcased at AMP 2025

Dec 3, 2025, 8:00 AM EST - 6 months ago

Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies

2025-11-24T11:15:34.000Z - 7 months ago

Bionano Genomics price target lowered to $7 from $11 at H.C. Wainwright

Nov 13, 2025, 4:30 PM EST - 7 months ago

Bionano Genomics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

Bionano Genomics Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

Bionano Genomics Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

Bionano Genomics Slides: Q3 2025

Nov 13, 2025, 4:01 PM EST - 7 months ago

Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress

2025-11-06T13:33:02.000Z - 7 months ago

Bionano Genomics announces publication of study on OGM

Nov 6, 2025, 8:00 AM EST - 7 months ago

Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia

Oct 30, 2025, 4:05 PM EDT - 7 months ago

Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025

2025-10-15T14:15:47.000Z - 8 months ago

Bionano Genomics participates in a conference call with H.C. Wainwright

Oct 15, 2025, 10:00 AM EDT - 8 months ago

Bionano Genomics Transcript: H.C. Wainwright @ Home Event

Oct 7, 2025, 8:00 AM EDT - 8 months ago

Bionano to Participate in the H.C. Wainwright @ Home Event

Sep 17, 2025, 5:00 PM EDT - 9 months ago

Bionano Genomics, Inc. Announces Closing of $10 Million Public Oﬀering

2025-09-16T13:15:38.000Z - 9 months ago

Bionano Genomics prices 5M shares at $2.00 in public offering

2025-09-16T11:10:39.000Z - 9 months ago

Bionano Genomics issues book series related to OGM in chromoanagenesis research

Sep 16, 2025, 7:00 AM EDT - 9 months ago

Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology

Sep 15, 2025, 7:00 AM EDT - 9 months ago

CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders

Sep 11, 2025, 8:00 AM EDT - 9 months ago

Bionano Genomics Registration statement: Registration Filing

Sep 8, 2025, 3:00 PM EDT - 9 months ago

Bionano Genomics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Aug 25, 2025, 8:00 AM EDT - 10 months ago

Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 14, 2025, 4:30 PM EDT - 10 months ago

Bionano Genomics Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 10 months ago

Bionano Genomics Quarterly report: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 10 months ago

Bionano Genomics Earnings release: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 10 months ago

Bionano Genomics Slides: Q2 2025

Aug 14, 2025, 4:01 PM EDT - 10 months ago

Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress

Aug 13, 2025, 3:00 PM EDT - 10 months ago

Bionano Genomics Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 7, 2025, 8:00 AM EDT - 10 months ago

Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL

Aug 6, 2025, 8:00 AM EDT - 10 months ago

Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 31, 2025, 4:05 PM EDT - 11 months ago

Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025

Jun 11, 2025, 1:00 PM EDT - 1 year ago

Bionano Genomics Transcript: AGM 2025

May 19, 2025, 8:00 AM EDT - 1 year ago

Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders

May 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings Call Transcript: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Quarterly report: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings release: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Slides: Q1 2025

May 14, 2025, 4:01 PM EDT - 1 year ago

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

May 13, 2025, 8:00 AM EDT - 1 year ago

Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies

May 7, 2025, 4:01 PM EDT - 1 year ago

Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025

May 2, 2025, 9:30 AM EDT - 1 year ago

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease

Apr 18, 2025, 8:00 AM EDT - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings Call Transcript: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Annual report: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings release: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Slides: Q4 2024

Mar 31, 2025, 4:01 PM EDT - 1 year ago

Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect

Mar 18, 2025, 8:00 AM EDT - 1 year ago

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting

Mar 14, 2025, 8:00 AM EDT - 1 year ago

Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025

Mar 13, 2025, 9:00 AM EDT - 1 year ago

Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML

Jan 22, 2025, 4:05 PM EST - 1 year ago

Bionano Announces Effective Date of Reverse Stock Split

Jan 15, 2025, 1:00 PM EST - 1 year ago

Bionano Genomics Transcript: EGM 2025

Jan 8, 2025, 7:00 AM EST - 1 year ago

Bionano Genomics Registration statement: Registration Filing

Jan 6, 2025, 4:30 PM EST - 1 year ago

Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Jan 3, 2025, 2:34 PM EST - 1 year ago

Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Jan 3, 2025, 7:00 AM EST - 1 year ago

Bionano Genomics Registration statement: Registration Filing

Dec 31, 2024, 3:26 PM EST - 1 year ago

Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway

Dec 23, 2024, 8:30 AM EST - 1 year ago

Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis

Dec 19, 2024, 7:00 AM EST - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing

Dec 5, 2024, 7:00 AM EST - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing

Dec 5, 2024, 7:00 AM EST - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing

Nov 25, 2024, 7:00 AM EST - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing

Nov 13, 2024, 4:30 PM EST - 1 year ago

Bionano Genomics Earnings Call Transcript: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Bionano Genomics Quarterly report: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Bionano Genomics Earnings release: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Bionano Genomics Slides: Q3 2024

Nov 13, 2024, 4:01 PM EST - 1 year ago

Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress

Nov 4, 2024, 4:14 AM EST - 1 year ago

Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry

Oct 31, 2024, 4:30 PM EDT - 1 year ago

Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Oct 31, 2024, 8:10 AM EDT - 1 year ago

Bionano Adjourns Special Meeting of Stockholders to November 27, 2024

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing

Oct 10, 2024, 8:00 AM EDT - 1 year ago

Bionano Announces Preliminary 3Q 2024 Revenues and Cash

Lstreak Jun. 8 at 5:49 PM

$BNGO https://finance.yahoo.com/markets/stocks/articles/bionano-genomics-bngo-upgraded-buy-160005428.html

0 · Reply

MisterNessuno Jun. 8 at 4:28 PM

$BNGO Is obvius that this company will be sold by the end of year (Mr E, Alka,retire senior secured, ecc)

0 · Reply

Peaceouty Jun. 6 at 8:36 PM

$BNGO that was THE smartest person in this entire company.

0 · Reply

SuperGreenToday Jun. 6 at 12:42 AM

$BNGO

0 · Reply

focafoca99 Jun. 5 at 9:23 PM

$BNGO notified its Chief Medical Officer Alka Chaubey, Ph.D. will resign effective July 5, 2026. https://www.rapidticker.com/news/bngo-sec-filing-01375e

1 · Reply

JumpStarting Jun. 5 at 7:32 PM

$TLRY $FLNA $BNGO $SPX Good news should not be bad news!

0 · Reply

AdmiralTweezers Jun. 3 at 10:39 PM

$ILMN why are these genomics tech companies up?? $BNGO ???

1 · Reply

JinUzuki Jun. 3 at 9:39 PM

$BNGO GREEN IN A SEA OF RED BABY!!!! LFG!!!!……………

0 · Reply

Xochi_Research_Group Jun. 3 at 8:23 PM

$BNGO is it true ❓ is homolin finally gone ❓ may need to scale back in here.....

0 · Reply

geistvonspiez Jun. 3 at 6:50 PM

$BNGO i can smell something.

0 · Reply

Bedtimereminder Jun. 3 at 6:25 PM

$BNGO time!!!!

0 · Reply

Nomi777 Jun. 2 at 3:04 PM

$BNGO The thesis is 100% a razor-and-blade model now. The new $1,263 reimbursement code is a massive catalyst, but with limited unrestricted cash, can they scale flow cell sales fast enough to avoid heavy dilution before 2027? Keeping this on a strict watch list until Q3/Q4 filings to see the real data. What are you guys seeing on clinical adoption?

1 · Reply

Lstreak May. 28 at 5:18 PM

$BNGO Got a little bit today see what happens; hopefully this will start turning around.

0 · Reply

focafoca99 May. 28 at 12:16 PM

$BNGO retired its outstanding senior secured convertible debentures, eliminating $20M of secured debt and boosting financial flexibility. https://www.rapidticker.com/news/bngo-bionano-announces-full-retirement-of-3552d0

0 · Reply

focafoca99 May. 28 at 12:10 PM

$BNGO repaid its senior secured convertible debentures in full, extinguishing the debt. https://www.rapidticker.com/news/bngo-sec-filing-0347a0

0 · Reply

tomrats May. 27 at 11:49 AM

$BNGO stock is down 99.97% I lost about $700,000 on the Stock years ago. It is absolute trash. It’s a scam. The CEO should be arrested.

3 · Reply

jerrik May. 26 at 6:06 PM

$BNGO This is doing the same thing $XERS did a few years ago. But $XERS finally got it's leg up. This is pretty cheap right now.

0 · Reply

m1ster_leboeuf May. 26 at 2:06 PM

$BNGO Nice study (like always) but no interest or revenue on the product.

0 · Reply

focafoca99 May. 26 at 12:40 PM

$BNGO showcases its largest T-ALL optical genome mapping study, reporting 97.8% detection versus 55% by conventional karyotyping. https://www.rapidticker.com/news/bngo-bionano-announces-largest-ogm-study-1d5ea3

0 · Reply

DARKP00L May. 26 at 12:32 PM

$BNGO 08:03 on May. 26 2026 Bionano Genomics Announces Publication Of Largest OGM Study Of T-Cell Acute Lymphoblastic Leukemia With 97.8% Detection Rate #tradeideas

0 · Reply

Pinto72 May. 25 at 10:28 PM

$BNGO Rookie here. Is this a good long term investment? Asking @Landsman @MessengerOfMoistville @YourDadsDildo @CristoferAtlantis @Rivermiles and @pvpat4

2 · Reply

Majed94 May. 21 at 12:37 AM

$BNGO Does anyone have a reading or prediction about the stock price? Is it possible we'll see it reach $50, or is that impossible? If anyone has any information, please come and tell me so we can discuss it

2 · Reply

Market Cap	13.43M
Revenue (ttm)	28.51M
Net Income (ttm)	-26.40M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-92.60%
Debt to Equity Ratio	0.00

Volume	172,100
Avg Vol	153,802
Day's Range	N/A - N/A
Shares Out	11.48M
Stochastic %K	5%
Beta	1.65
Analysts	Strong Sell
Price Target	$5.00